Literature DB >> 24037884

Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study.

Tim I M Korevaar1, Sarah Schalekamp-Timmermans, Yolanda B de Rijke, W Edward Visser, Willy Visser, Sabine M P F de Muinck Keizer-Schrama, Albert Hofman, H Alec Ross, Herbert Hooijkaas, Henning Tiemeier, Jacoba J Bongers-Schokking, Vincent W V Jaddoe, Theo J Visser, Eric A P Steegers, Marco Medici, Robin P Peeters.   

Abstract

CONTEXT: Premature delivery is an important risk factor for child mortality and psychiatric, metabolic, and cardiovascular disease later in life. In the majority of cases, the cause of prematurity cannot be identified. Currently, it remains controversial whether abnormal maternal thyroid function during pregnancy increases the risk of premature delivery. Therefore, we investigated the relation between maternal serum thyroid parameters and the risk of premature delivery in a large prospective population-based study.
DESIGN: Serum TSH, free T4 (FT4), T4, and TPO antibodies (TPOAbs) were determined during early pregnancy in 5971 pregnant women from the Generation R study. Data were available on maternal age, parity, smoking, socioeconomic status, ethnicity, maternal anthropometrics, and urinary iodine levels.
RESULTS: Of all women, 5.0% had a premature delivery (<37 weeks), 4.4% had a spontaneous premature delivery, and 1.4% had a very premature delivery (<34 weeks). High TSH levels and subclinical hypothyroidism were associated with premature delivery but not with spontaneous premature delivery. Maternal hypothyroxinemia was associated with a 2.5-fold increased risk of premature delivery, a 3.4-fold increased risk of spontaneous premature delivery, and a 3.6-fold increased risk of very premature delivery (all P < .01). TPOAb positivity was associated with a 1.7-fold increased risk of premature delivery (P = .01), a 2.1-fold increased risk of spontaneous premature delivery (P = .02), and a 2.5-fold increased risk of very premature delivery (P = .04). These effects remained similar after correction for TSH and FT4 levels.
CONCLUSIONS: Hypothyroxinemia and TPOAb positivity are associated with an increased risk of premature delivery. The increased risk in TPOAb-positive women seems to be independent of thyroid function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037884     DOI: 10.1210/jc.2013-2855

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  58 in total

Review 1.  Thyroid disease in pregnancy: new insights in diagnosis and clinical management.

Authors:  Tim I M Korevaar; Marco Medici; Theo J Visser; Robin P Peeters
Journal:  Nat Rev Endocrinol       Date:  2017-08-04       Impact factor: 43.330

Review 2.  Maternal Hypothyroxinemia-Induced Neurodevelopmental Impairments in the Progeny.

Authors:  Hui Min; Jing Dong; Yi Wang; Yuan Wang; Weiping Teng; Qi Xi; Jie Chen
Journal:  Mol Neurobiol       Date:  2015-02-11       Impact factor: 5.590

3.  The Generation R Study: Biobank update 2015.

Authors:  Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

Review 4.  Update on a new controversy in endocrinology: isolated maternal hypothyroxinemia.

Authors:  R M Furnica; J H Lazarus; D Gruson; C Daumerie
Journal:  J Endocrinol Invest       Date:  2014-11-05       Impact factor: 4.256

5.  Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women.

Authors:  Liang-Miao Chen; Qian Zhang; Guang-Xin Si; Qing-Shou Chen; En-ling Ye; Le-Chu Yu; Meng-Meng Peng; Hong Yang; Wen-Jun Du; Chi Zhang; Xue-Mian Lu
Journal:  Endocrine       Date:  2014-09-11       Impact factor: 3.633

6.  Thyroid-stimulating hormone, anti-thyroid antibodies, and pregnancy outcomes.

Authors:  Torie C Plowden; Enrique F Schisterman; Lindsey A Sjaarda; Neil J Perkins; Robert Silver; Rose Radin; Keewan Kim; Noya Galai; Alan H DeCherney; Sunni L Mumford
Journal:  Am J Obstet Gynecol       Date:  2017-09-14       Impact factor: 8.661

7.  Impact of maternal thyroid autoantibodies positivity on the risk of early term birth: Ma'anshan Birth Cohort Study.

Authors:  Yan Han; Lei-Jing Mao; Xing Ge; Kun Huang; Shuang-Qin Yan; Ling-Ling Ren; Shu-Qing Hong; Hui Gao; Jie Sheng; Yuan-Yuan Xu; Wei-Jun Pan; Peng Zhu; Jia-Hu Hao; De-Fa Zhu; Fang-Biao Tao
Journal:  Endocrine       Date:  2018-03-22       Impact factor: 3.633

8.  Levothyroxine monotherapy versus levothyroxine and selenium combination therapy in chronic lymphocytic thyroiditis.

Authors:  L Yu; L Zhou; E Xu; Y Bi; X Hu; X Pei; G Jin
Journal:  J Endocrinol Invest       Date:  2017-05-22       Impact factor: 4.256

9.  2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children.

Authors:  John Lazarus; Rosalind S Brown; Chantal Daumerie; Alicja Hubalewska-Dydejczyk; Roberto Negro; Bijay Vaidya
Journal:  Eur Thyroid J       Date:  2014-06-07

10.  Cross-sectional associations between urinary triclosan and serum thyroid function biomarker concentrations in women.

Authors:  Julianne Skarha; Lidia Mínguez-Alarcón; Paige L Williams; Tim I M Korevaar; Ralph A de Poortere; Maarten A C Broeren; Jennifer B Ford; Melissa Eliot; Russ Hauser; Joseph M Braun
Journal:  Environ Int       Date:  2018-11-23       Impact factor: 9.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.